Dr Samal Nauhria samal@windsor .edu Plasma cell lesions Dr Samal Nauhria samal@windsor .edu.

Slides:



Advertisements
Similar presentations
WHOLE-BODY-LOW-DOSE MDCT IN THE INVESTIGATION OF MULTIPLE MYELOMA (MM) – A NEW APPROCH AND OUR EXPERIENCE Kamenetsky Natalya (1), Rachmilewitz Eliezer.
Advertisements

Myeloma Round Table Beth Faiman MSN, APRN-BC, AOCN Nurse Practitioner, Cleveland Clinic Pre-Doctoral Fellow, Case Western Reserve.
Serum Electrophoresis AND IMMUNOFIXATION june 2013 Dr. Nitin A Inamdar Department of Biochemistry Tata Memorial Center
Rick Allen.  A malignant proliferation of plasma cells derived from a single clone, with multifocal involvement of the skeleton.
Tabuk University 1 3 rd Year – Level 5 – AY Faculty of Applied Medical Sciences Department Of Medical Lab. Technology.
Show and Tell FIRM B - RED. Our team Dr. Clarke & Dr. Vargas Shinoj & Arvind Jacob & Muneeza Chloe, Lauren & Njiye.
Serum Protein Electrophoresis
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Staff Oncologist, Mayo Clinic Arizona
Dr A. Mousavi.  15 % of all malignant white cell diseases  1% of all cancer deaths  Group of lymphoid neoplasms of terminally differentiated B-cells.
Chapter 21 Monoclonal Gammopathies
CLS 404 Immunology Protein Abnormalities
Diagnosis of Paraprotein Diseases CLS 404 Immunology Protein Abnormalities.
Waldenström’s Macroglobulinemia And the Hyperviscosity Syndromes.
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
Plasma cell neoplasm Plasma cell Ig M component, para protein Monoclonal gammopathy.
Chronic lymphocytic leukemia (1)
Waldenstrom’s Macroglobulinemia
Terry Kotrla, MS, MT(ASCP)BB Topic 3 Autoimmunity Part 8 Immunoproliferative Diseases.
By: Dr Jeevan Divakaran. Presenter: Dr Abiodun Mark Akanmode.
LYMPHOMA.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
MULTIPLE MYELOMA (MM).
Diagnosis and Treatment of Multiple Myeloma Mark B. Juckett MD Division of Hematology University of Wisconsin December 11, 2002.
Multiple Myeloma Alan Johns, M.D. Kristine Krafts, M.D.
Understanding Your Blood Work
Hematopoietic and Lymphoid Neoplasm Project. Acknowledgments American College of Surgeons (ACOS) Commission on Cancer (COC) Canadian Cancer Registries.
Multiple Myeloma Definition:
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Plasma cell Disorders S. Sami Kartı, MD, Prof.. Plasma cells  Terminally differentiated cells of B- lymphocyte lineage  Produce antibodies  Normal.
IMMUNOCHEMISTRY PROFILES Dr. Thomas Williams. TESTS DISEASES CASES.
Multiple Myeloma Definition:
Epidemiology 12,000 deaths in United States per year
CASE 5 56 yr-old man HIV Asymptomatic CD4 840 HIV viral load
LYMPHOPROLIFERATIVE DISORDERS
Multiple Myeloma Morning Report July 21, 2009 Lindsay Kruska.
Justin A. Crocker.  1 of the monoclonal gammopathies  Neoplastic proliferation of immunoglobulin producing plasma cells (single clone), often resulting.
MLAB 1415: H EMATOLOGY K ERI B ROPHY -M ARTINEZ Chapter 26: Lymphoid Malignancies Part Two.
Biological functions transport –albumin –transferin –ceruloplasmin –haptoglobin oncotic pressure regulation coagulation immunity.
Malignant bone tumors. Osteosarcoma Pathology: Also called osteogenic sarcoma. It’s a primary malignant bone tumor produces osteoid tissue. It destroys.
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
Plasma cell dyscrasias. Multiple Myeloma By Dr. Muna A. Kashmool.
Jesse C James MD AM Report May 7,  Proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein  Malignant.
Chicago Medical School
Myeloproliferative Lymphoproliferative & Immunoproliferative disorders.
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Plasma cell Dyscrasia 1- B.M.G. 2- Multiple Myeloma 3- Waldenstrom Macroglubolenemia 4- Heavy Chain disease 5- Amyloidosis.
M. Multiple Myeloma Malignant proliferation of plasma cells. Malignant proliferation of plasma cells. Normal plasma cell form Ig which contain heavy and.
Multiple Myeloma March 13, 2012 Suzanne R. Fanning, DO Greenville Health System.
Para-proteinaemias Para-proteinaemias dr.Mousa Qasim Hussein Assistant Professor 7 th march 2016.
Chapter 11 Lymphatic System Disorders Mitzy D. Flores, MSN, RN.
CONCEPT MAP CONCEPT MAP. 42 y/o male, CC: EDEMA ON BILATERAL EXTREMITIES. Diagnosed with a benign cystic lesion 8 yrs ago S/Sx: BONE PAINS, EASY FATIGUABILITY.
Department of Nephrology Hypercalcemia R4 Song Se-bin.
Case Study Multiple Myeloma.
Miten R. Patel, MD Cancer Specialists of North Florida
Para-proteinaemias dr.Mousa Qasim Hussein Assistant Professor
Paraproteinaemias. Multiple myeloma. Amyloidosis. Part 2 Dr
MULTIPLE MYELOMA (MM) objective: definition of MM Biochemical investigation in Diagnosis.
MLAB Hematology Keri Brophy-Martinez
Dr WAQAR ASST. PROFESSOR INTERNAL MEDICINE
MLAB Hematology Fall 2007 Keri Brophy-Martinez
Multiple myeloma (MM) & related disorders
by Qin Huang Blood Volume 122(1):6-6 July 4, 2013
Multiple Myeloma and Understanding your Labs
Myeloma: Symptoms to diagnosis Can we do better?
PARAPRTEINAEMIA and MULTIPLE MYELOMA
Bence Jones protein The Bence Jones protein was described by the English physician Henry Bence Jones in 1847 and published in 1848.Henry Bence Jones The.
Presentation transcript:

Dr Samal Nauhria samal@windsor .edu Plasma cell lesions Dr Samal Nauhria samal@windsor .edu

Plasma Cell Lesions Multiple Myeloma Solitary Plasmacytoma/myeloma. Lympho-plasmacytic Lymphoma Heavy-chain Disease Primary Amyloidosis MGUS

Multiple Myeloma Median age at diagnosis - 70 years M/C in males and in people of African origin Principally involves bone marrow and associated with lytic lesions throughout the skeletal system Evidence of end-organ damage includes Calcium elevation, Renal insufficiency, Anemia, and Bone lesions (CRAB)

Multiple Myeloma Most frequent M protein is IgG (60%), followed by IgA (20% to 25%) In 15 to 20% cases, the plasma cells produce only κ or λ light chains Bence-Jones proteins: free κ or λ light chains that are excreted in the urine

Pathogenesis of Myeloma Dysregulation of D cyclins is common IL-6 produced by fibroblasts, macrophages in the bone marrow stroma stimulates proliferation of myeloma cells Myeloma Cells secrete IL-1β, TNF, IL-6 which stimulate production of RANK-ligand  increased osteoclast  bone resorption

Pathogenesis of Myeloma Immunosuppression: Although plasma contains increased Ig’s owing to M protein, the levels of functional antibodies are profoundly depressed, leaving patients at high risk for bacterial infections

Morphology Multifocal destructive skeletal lesions, most commonly involving the VERTEBRAL COLUMN, ribs, skull, pelvis, femur, clavicle, and scapula Punched-out defects 1 to 4 cm in diameter Arise in medullary cavityerode cancellous bone progressively destroy the cortical bone Pathologic fractures, mostly in vertebra or femur

Multiple myeloma with multiple vertebral fractures at the thoracic and lumbar levels

Microscopic examination Increased numbers of plasma cells > 30% of the cellularity Abnormal features Prominent nucleoli Abnormal cytoplasmic inclusions(Ig) In terminal stages, a leukemic picture may emerge

PLASMA CELLS Terminally differentiated B-cells Not normally found in peripheral blood Account for < 3.5% of nucleated cells in the bone marrow

Oval cells with cart-wheel nucleus Cytoplasm is basophilic blue Nucleus is oval or round and typically placed eccentrically A hof is present adjacent to the nucleus contains Golgi apparatus

RUSSELL BODIES Globules (2-3 μm) of accumulated immunoglobulins in the cytoplasm of plasma cells Usually round May be found in normal bone marrow 1st described by William Russell

MOTT CELLS/MORULA CELLS Plasma cells crowded with Russell bodies An obstruction blocks the release of Golgi secretions These cells can be found in any case of chronic plasmacytosis

FLAME CELLS Eosinophilic torn cytoplasm Usually associated with IgA myeloma

DUTCHER BODIES Immunoglobulin filled cytoplasm invaginating into the nucleus creating the appearance of an intranuclear inclusion PAS +ve Identified by Dutcher and Fahey

Clinical Features Pathologic fractures Bone Pain Vertebral fracture may lead to spinal cord impingement Hypercalcemia from bone resorption Neurologic manifestations (confusion, lethargy) Renal dysfunction Symptoms related to hyperviscosity Anemia: due to marrow replacement by tumor cells and suppression of hematopoiesis Recurrent infections with bacteria Common cause of death**

Renal findings Renal insufficiency (in 50% of patients) Proteinaceous tubular casts Casts are composed of BJ protein, which is nephrotoxic and damages tubular epithelium Biopsy reveals an intratubular multinucleated giant cell reaction Nephrocalcinosis Hypercalcemia leads to metastatic calcification of the tubular basement membranes in the collecting ducts Calcium deposits are a common cause of acute renal failure in multiple myeloma AL-type amyloidosis (5% to 10% of patients)

Diagnosis Clinically suspected when focal, punched-out skeletal defects are present - especially in vertebrae Electrophoresis of the serum and urine - monoclonal complete Ig or monoclonal free Ig light chain Examination of bone marrow: to confirm plasma cell proliferation

SERUM PROTEIN ELECTROPHORESIS Useful in quantitating the M protein and shows a monoclonal spike Does not specify which M protein is increased (e.g., IgG, IgA, IgM)

Other Tests- Serum immunofixation electrophoresis Provides a characterization of the M protein (heavy and light chain subclass; e.g., IgGκ or IgGλ; IgMκ or IgMλ) Urine protein electrophoresis Identifies BJ protein (free light chains) and quantitates the amount of light chains in the urine But not specify whether the light chains are κ or λ Urine immunofixation electrophoresis Characterizes whether BJ protein is κ or λ Serum for free light chains Detects and quantitates κ and λ light chains in serum More sensitive for detecting light chains than any of the urine methodologies listed above

Treatment and Prognosis Progressive disease, median survival of around 4 to 6 years Not curable Autologous stem cell transplantation - dramatically improved survival New therapies Proteasome inhibitors (induce plasma cell apoptosis) Thalidomide analogues (alter the marrow microenvironment to inhibit myeloma cell growth and survival)

Solitary Plasmacytoma/myeloma Low or no serum and urine M protein No malignant plasma cells in the bone marrow Skeletal Plasmacytoma Occurs in same locations as multiple myeloma Progresses to full-blown multiple myeloma over 5 to 10 years Soft tissue Plasmacytoma Most often in upper respiratory tract Spreads infrequently, cured by local resection

Lymphoplasmacytic Lymphoma (Waldenström macroglobulinemia) Affects older persons; peak incidence between 6 -7th decades Tumor cells secrete an M protein (commonly IgM) Mixture of B cells ranging from small lymphocytes to plasmacytic lymphocytes to plasma cells Involves lymph nodes, bone marrow, and spleen at presentation

Lymphoplasmacytic Lymphoma ↑IgM causes viscous blood - Waldenström Macroglobulinemia No free light chains or Bence Jones proteinuria No lytic bone lesions Renal disease and amyloidosis are rare

Waldenström Macroglobulinemia Visual impairment: tortuosity and distention of retinal veins; retinal hemorrhages and exudates Neurologic problems - headaches, dizziness, tinnitus, deafness, and stupor, (from sluggish blood flow and sludging) Bleeding - formation of complexes between macroglobulins and clotting factors as well as interference with platelet function Cryoglobulinemia - precipitation of macroglobulins at low temperatures - Raynaud phenomenon and cold urticaria

Heavy-Chain Disease Proliferations in which only heavy chains are produced IgA heavy-chain disease: more common, has a predilection for lymphoid tissues in which IgA normally is produced (Small intestine, Respiratory tract) IgG heavy-chain disease: diffuse lymphadenopathy and hepatosplenomegaly

Primary Amyloidosis Monoclonal proliferation of plasma cells that secrete free light chains underlies primary amyloidosis Amyloid deposits (AL type) consist of partially degraded light chains

Monoclonal Gammopathy of Undetermined Significance(MGUS) Asymptomatic monoclonal gammopathy Serum M proteins in 1 to 3% of healthy persons > 50 years < 3 g/dL of monoclonal protein in serum No Bence Jones proteinuria Precursor lesion with a tendency to evolve to multiple myeloma (rate of 1% per year) Diagnosis made only after careful exclusion of other monoclonal gammopathies, particularly multiple myeloma The clonal plasma cells in MGUS contain the same chromosomal translocations found in full-blown multiple myeloma